Benjamin R. Saville

Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial

Christopher Butler, Richard Hobbs, Oghenekome Gbinigie et al. · The Lancet · 2022 · 406 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +7

Trial of Early Minimally Invasive Removal of Intracerebral Hemorrhage

Gustavo Pradilla, Jonathan J. Ratcliff, Alex Hall et al. · New England Journal of Medicine · 2024 · 402 citations

Medicine, Neurosurgery, Surgery +17

Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial

Christopher Butler, Jienchi Dorward, Ly‐Mee Yu et al. · The Lancet · 2021 · 318 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +12

Efficiencies of platform clinical trials: A vision of the future

Benjamin R. Saville, Scott Berry · Clinical Trials · 2016 · 316 citations

Medicine, Pharmacoeconomics, Experimental Design +14

Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial

Ly‐Mee Yu, Mona Bafadhel, Jienchi Dorward et al. · The Lancet · 2021 · 310 citations · Full text

Pharmacy, Community Medicine, Pharmacotherapy +14